Insiders · HBIO

Katherine A. Eade

Director at Harvard Bioscience Inc (HBIO)

Katherine A. Eade has filed 10 insider reports with the SEC since May 2021, as director at Harvard Bioscience Inc (HBIO) and director at Vaxxinity, Inc. (VAXX). The latest filing, on June 12, 2026, reports grant or award at Harvard Bioscience Inc (HBIO).

Filings
10
Companies
2
Bought on market
None
Sold on market
None

Companies where Katherine A. Eade is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Harvard Bioscience Inc logo
HBIO
Harvard Bioscience Inc
Director58,669$8.66Jun 12, 2026
Vaxxinity, Inc. logo
VAXX
Vaxxinity, Inc.
Directorsince February 2023Jun 26, 2023

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Katherine A. Eade with

Other insiders at the same companies

Questions about Katherine A. Eade

What is Katherine A. Eade's role at Harvard Bioscience Inc?
Katherine A. Eade reports to the SEC as director at Harvard Bioscience Inc (HBIO), according to the latest filing on June 12, 2026. Katherine A. Eade has also filed as director at Vaxxinity, Inc. (VAXX).
How many shares does Katherine A. Eade own?
After the latest filing that states it, Katherine A. Eade directly owned 58,669 shares of Harvard Bioscience Inc (HBIO). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Katherine A. Eade bought or sold stock recently?
No open-market purchases or sales by Katherine A. Eade are on file. The filings report grant or award.
How do I get alerts when Katherine A. Eade files?
Follow Katherine A. Eade on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Katherine A. Eade (SEC CIK 0001721318). Totals count each trade once, skipping amendments whose original is on file, from May 27, 2021 on. View on SEC EDGAR · Get this as JSON